We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$81.9M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$40.8M
3
USIG icon
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
+$33.9M
4
AAPL icon
Apple
AAPL
+$18.9M
5
ATVI
Activision Blizzard
ATVI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFE icon
2401
New Fortress Energy
NFE
$93M
$148K ﹤0.01%
3,926
-54
-1% -$1.86K
TCBX icon
2402
Third Coast Bancshares
TCBX
$766M
$148K ﹤0.01%
7,437
– –
SB icon
2403
Safe Bulkers
SB
$781M
$148K ﹤0.01%
+37,575
New +$132K
ABUS icon
2404
Arbutus Biopharma
ABUS
$906M
$147K ﹤0.01%
58,981
– –
OM icon
2405
Outset Medical
OM
$79.9M
$147K ﹤0.01%
1,807
– –
HLLY icon
2406
Holley
HLLY
$362M
$147K ﹤0.01%
30,092
– –
LXFR icon
2407
Luxfer Holdings
LXFR
$457M
$146K ﹤0.01%
16,359
– –
REFI
2408
Chicago Atlantic Real Estate Finance
REFI
$264M
$146K ﹤0.01%
9,025
– –
SKIN icon
2409
SkinHealth Systems
SKIN
$85.9M
$146K ﹤0.01%
46,838
– –
FDBC icon
2410
Fidelity D&D Bancorp
FDBC
$321M
$145K ﹤0.01%
2,506
– –
PBPB
2411
DELISTED
Potbelly
PBPB
$145K ﹤0.01%
13,924
– –
DOUG icon
2412
Douglas Elliman
DOUG
$183M
$145K ﹤0.01%
49,136
– –
SPOK icon
2413
Spok Holdings
SPOK
$230M
$145K ﹤0.01%
9,363
– –
NMRA icon
2414
Neumora Therapeutics
NMRA
$321M
$145K ﹤0.01%
+8,487
New +$104K
AVIR icon
2415
Atea Pharmaceuticals
AVIR
$406M
$144K ﹤0.01%
47,234
– –
FORR icon
2416
Forrester Research
FORR
$224M
$144K ﹤0.01%
5,365
– –
ONTF
2417
DELISTED
ON24
ONTF
$144K ﹤0.01%
18,243
– –
AVD icon
2418
American Vanguard Corp
AVD
$62.8M
$144K ﹤0.01%
13,084
– –
PLCE icon
2419
Children's Place
PLCE
$53.4M
$143K ﹤0.01%
6,154
– –
VMD icon
2420
Viemed Healthcare
VMD
$349M
$142K ﹤0.01%
18,101
– –
ELAN icon
2421
Elanco Animal Health
ELAN
$11.2B
$142K ﹤0.01%
9,535
-183
-2% -$2.07K
JOUT icon
2422
Johnson Outdoors
JOUT
$512M
$142K ﹤0.01%
2,659
– –
VYGR icon
2423
Voyager Therapeutics
VYGR
$198M
$142K ﹤0.01%
16,821
– –
EVCM icon
2424
EverCommerce
EVCM
$1.79B
$142K ﹤0.01%
12,870
– –
RRBI icon
2425
Red River Bancshares
RRBI
$681M
$142K ﹤0.01%
2,529
– –
95 96
97
98 99

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.